UNSPSC 51271923: Procaine pyroglutamate

This classification denotes an anesthetic agent with the molecular formula C13H20N2O2.C5H7NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W84930057W, chemically known as benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester, compd. with 5-oxoproline (1:1), but more generally known as procaine pyroglutamate, which bears US NIH Compound Identifier 25097. European Medicines Agency schedules procaine pyroglutamate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10056MIG.

Most nations, for tariff purposes, schedule procaine pyroglutamate under HS 29224995. SMILES: CCN(CC)CCOC(=O)C1CCC(CC1)N.C1CC(=O)N[C@@H]1C(=O)O.

UNSPSC 51271923 Procaine pyroglutamate is a Commodity code that in recent state and local procurement reflects a much broader scope than its nominal product — state and local jurisdictions are using this code to solicit generic multi-source pharmaceuticals and over-the-counter products for statewide and multistate distribution networks. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the issuing body driving activity under this code. Vendors supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencala, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and must demonstrate compliance with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), and FDA requirements. Contracts require vendors to maintain relationships with at least two of the three wholesalers, support electronic data interchange (EDI) capability, provide pricing in multiple formats (flat price, net price, or WAC-minus), and carry comprehensive insurance including $5 million commercial general liability, $2 million network security and privacy liability, and $2 million professional liability.

MMCAP's activity spans Minnesota and Oregon across state facilities and participating local jurisdictions. The Minnesota Department of Administration issued an RFP (Solicitation Number S1070000015802) posted January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts effective July 1, 2026. Evaluation weighting heavily favors price competitiveness (75 percent), with smaller allocations for fixed pricing (10 percent), price formats and compliance (5 percent each), EDI capability (5 percent), and the 3 percent administrative fee agreement (5 percent). Products must be available in the marketplace by May 15, 2026, and carry a minimum one-year expiration date from manufacture plus six-month shelf life. No specific dollar values or set-aside designations are disclosed; MMCAP reserves the right to award single, dual, or multiple vendors based on therapeutic considerations and member-specific needs.